Forefront Wealth Management’s Novo Nordisk NVO Stock Holding History

Forefront Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.29M	Buy	+25,451	New	+$1.3M	0.93%	32

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Forefront Wealth Management's NVO Position: Q4 2025 in Review

Forefront Wealth Management opened a new position in Novo Nordisk (NVO) in Q4 2025: 25,451 shares worth $1.29M. The stake represents 0.93% of the portfolio and ranks #32 among its holdings.

1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

Forefront Wealth Management held 25,451 shares of Novo Nordisk worth $1.29M as of Q4 2025.
Novo Nordisk was a new Forefront Wealth Management position in Q4 2025.
Novo Nordisk made up 0.93% of Forefront Wealth Management's portfolio in Q4 2025, its #32 holding.
1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Forefront Wealth Management's 13F filing for Q4 2025, filed 23 Jan 2026.